HRTX
HRTX
NASDAQ · Biotechnology

Heron Therapeutics Inc

$0.33
-0.03 (-9.30%)
Analyst Consensus
Strong Sell
7
Analysts
Moderate
Coverage
Buy 0 0%
Hold 4 57%
Sell 3 43%
Price Target
Analyst Price Target +6,899.1% upside
Low Target $15.42
Average Target $22.81
High Target $25.92
Current Price $0.33
Current
$0.33
Target
$22.81
$15.42 $22.81 avg $25.92
Scenario Analysis
Bear Case
$15.42
4,631.5%
Low target
Base Case
$22.81
+6,899.1%
Avg target
Bull Case
$25.92
+7,853.4%
High target
Risk/Reward
1.7x
Balanced
Price in Context
52-Week High
$1.58
-79.4% from high
52-Week Low
$0.26
+24.9% from low
Target vs 52W High
$22.81
+1,343.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%